C-THAN
C-THAN will develop and apply innovative point-of-care (POC) and home-based technologies for diagnosis and monitoring of HIV, its co-morbidities (TB, viral hepatitis, virus-mediated cancers, etc.) and
C-THAN has assembled a scientific consortium including Northwestern University and Universities of Lagos, Ibadan, and Jos in Nigeria, Cape Town, Stellenbosch, and Witwatersrand in South Africa, Cheikh Anta Diop in Senegal, University of Sciences, Techniques and Technologies of Bamako in Mali, and Muhimbili University of Health and Allied Schiences in Tanzania.
News and Events
New Funding Opportunity: Have an innovative solution to detect HIV viral load?
The National Institute of Biomedical Imaging and Bioengineering’s (NIBIB) Point of Care Technology Research Network (POCTRN) is seeking innovative technologies that determine HIV viral load and accelerate their development towards deployment at point-of-care settings.
This program is designed to meet the significant unmet need to provide better viral load testing in point-of-care settings with technologies that are both sensitive and simple to use so that people living with HIV can be better informed of their infectiveness and response to antiretroviral therapy.
Awardees will receive:
- Up to $500k in funding to help support project acceleration
- Support provided to address business, regulatory, clinical, and technical elements
- Mentorship from highly experienced experts in all four categories
The deadline for this opportunity has passed.
Questions?
Please contact admin@poctrn.org.
The National Institute of Biomedical Imaging and Bioengineering’s (NIBIB) Point of Care Technology Research Network (POCTRN) is seeking innovative technologies that determine HIV viral load and accelerate their development towards deployment at point-of-care settings.
This program is designed to meet the significant unmet need to provide better viral load testing in point-of-care settings with technologies that are both sensitive and simple to use so that people living with HIV can be better informed of their infectiveness and response to antiretroviral therapy.
Awardees will receive:
- Up to $500k in funding to help support project acceleration
- Support provided to address business, regulatory, clinical, and technical elements
- Mentorship from highly experienced experts in all four categories
The deadline for this opportunity has passed.
Questions?
Please contact admin@poctrn.org.